Provided by Tiger Trade Technology Pte. Ltd.

Eterna Therapeutics Inc.

4.86
+0.34007.52%
Post-market: 4.950.0900+1.85%19:48 EDT
Volume:71.13K
Turnover:348.06K
Market Cap:7.93M
PE:-0.26
High:5.20
Open:4.53
Low:4.53
Close:4.52
52wk High:71.50
52wk Low:3.18
Shares:1.63M
Float Shares:1.22M
Volume Ratio:2.26
T/O Rate:5.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.6059
EPS(LYR):-55.8903
ROE:-320.72%
ROA:-105.57%
PB:2.48
PE(LYR):-0.09

Loading ...

Company Profile

Company Name:
Eterna Therapeutics Inc.
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
6
Office Location:
1035 Cambridge Street,Suite 18A,Cambridge,Massachusetts,United States
Zip Code:
02141
Fax:
- -
Introduction:
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Directors

Name
Position
James Bristol
Director and Chairman of the Board
Sanjeev Luther
President, Chief Executive Officer and Director
Elena Ratner
Director
Peter Cicala
Director
William Wexler
Director

Shareholders

Name
Position
Sanjeev Luther
President, Chief Executive Officer and Director
Sandra Gurrola
Senior Vice President, Finance